These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26787450)

  • 1. Anti-Müllerian hormone serum level and other markers associated with pregnancy outcome in oocyte donation.
    Delesalle AS; Robin G; Thomas-Desrousseaux P; Dewailly D; Catteau-Jonard S
    Reprod Biol Endocrinol; 2016 Jan; 14():4. PubMed ID: 26787450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation.
    Riggs R; Kimble T; Oehninger S; Bocca S; Zhao Y; Leader B; Stadtmauer L
    Fertil Steril; 2011 Jan; 95(1):410-2. PubMed ID: 20736131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K; Gelbaya TA; Laing I; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors.
    Polyzos NP; Stoop D; Blockeel C; Adriaensen P; Platteau P; Anckaert E; Smitz J; Devroey P
    Reprod Biomed Online; 2012 May; 24(5):532-9. PubMed ID: 22417669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum level of anti-mullerian hormone in early follicular phase as a predictor of ovarian reserve and pregnancy outcome in assisted reproductive technology cycles.
    Dehghani-Firouzabadi R; Tayebi N; Asgharnia M
    Arch Iran Med; 2008 Jul; 11(4):371-6. PubMed ID: 18588367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors.
    Nakhuda GS; Douglas NC; Thornton MH; Guarnaccia MM; Lobo R; Sauer MV
    Reprod Biomed Online; 2010 Jan; 20(1):42-7. PubMed ID: 20158986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive oocyte donation does not decrease serum anti-Müllerian hormone levels.
    Bukulmez O; Li Q; Carr BR; Leader B; Doody KM; Doody KJ
    Fertil Steril; 2010 Aug; 94(3):905-12. PubMed ID: 19631321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal antimüllerian hormone levels in oocyte donors: a national database analysis.
    Sarkar P; Zalles L; Caswell W; Stratton M; Devine K; Harris BS; Romanski PA
    Fertil Steril; 2024 Feb; 121(2):221-229. PubMed ID: 37949348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes.
    Styer AK; Gaskins AJ; Brady PC; Sluss PM; Chavarro JE; Hauser RB; Toth TL
    Fertil Steril; 2015 Nov; 104(5):1153-61.e1-7. PubMed ID: 26315051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors.
    Fabris AM; Cruz M; Iglesias C; Pacheco A; Patel A; Patel J; Fatemi H; García-Velasco JA
    Reprod Biomed Online; 2017 Aug; 35(2):139-144. PubMed ID: 28625761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A higher anti-Müllerian hormone level is associated with an increased chance of pregnancy in patients undergoing controlled ovarian stimulation and intrauterine insemination.
    Wang MH; Chen CH; Wang CW; Hsu MI; Tzeng CR
    J Obstet Gynaecol; 2015 Jan; 35(1):64-8. PubMed ID: 25010731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes.
    Martínez F; Clua E; Devesa M; Rodríguez I; Arroyo G; González C; Solé M; Tur R; Coroleu B; Barri PN
    Fertil Steril; 2014 Nov; 102(5):1307-11. PubMed ID: 25154677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.